the meaning of meaningful use - appeal academyappealacademy.com/wp-content/uploads/2013/02/... ·...

43
THE MEANING OF MEANINGFUL USE CHANGES IN THE STAGE 2 MU FINAL RULE Angel L. Moore, MAEd, RHIA Eastern AHEC REC

Upload: others

Post on 12-Aug-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

THE MEANING OF MEANINGFUL USE CHANGES IN THE STAGE 2 MU FINAL RULE

Angel L. Moore, MAEd, RHIA Eastern AHEC REC

Page 2: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

WE WILL BRIEFLY DISCUSS…

Meaningful Use (MU)

Incentive Programs, Eligibility & Timelines

Page 3: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

WE WILL BRIEFLY DISCUSS…

CMS Stage 2 Final Rule

Stage 2 Criteria

Stage 1 Changes

Additional Changes/Revisions (2013 and 2014)

Medicaid Volume Calculation Changes

Payment Adjustments & Hardship Exemptions

The meaning behind all of it…

Page 4: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

Meaningful Use

Page 5: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

• Health Information Technology for Economic and Clinical Health Act (HITECH Act)

• CEHRT

• Meaningful Use Requirements

• Core and Menu HIT Objectives

• Core and Menu Clinical Quality Measures

• Incentive

• Penalty

MEANINGFUL USE

Page 6: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

Using certified technology in EHR implementation to:

• Improve quality, safety, efficiency, and reduce health disparities

• Engage patients and family

• Improve care coordination, and population and public health

• Maintain privacy and security of patient health information

MEANINGFUL USE

Page 7: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical
Page 8: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

Incentive Programs,

Eligibility & Timelines

Page 9: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical
Page 10: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical
Page 11: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

WHEN DO I MEET STAGE 2 MEANINGFUL USE?

Page 12: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical
Page 13: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

Brief Synopsis of Stage 2

Changes (Core and Menu)

Page 14: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

STAGE 1 VS. STAGE 2

STAGE 1

• 15 CORE OBJECTIVES

• 5 OF 10 MENU OBJECTIVES

STAGE 2

• 17 CORE OBJECTIVES

• 3 OF 6 MENU OBJECTIVES

Page 15: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

STAGE 1 OBJECTIVES ≠ STAGE 2 OBJECTIVES

Implement drug-drug & drug-allergy interaction checks

Maintain up to date problem list

Maintain active medication list

Maintain active med allergy list

Page 16: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

STAGE 1 OBJECTIVES ≠ STAGE 2 OBJECTIVES

Report CQMs to CMS or the States

Conduct test to demonstrate capability to exchange key clinical health information among providers

Enable and have access to at least one drug formulary

Provide patients with timely electronic access to their health information within 4 days

Page 17: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

STAGE 1 MENU OBJECTIVES = STAGE 2 CORE OBJECTIVES

Clinical lab test results

Generate a list of patients

by diagnosis

Use EHR to

identify and

provide patient

education

Patient Reminders

Summary of Care

Medication Reconciliation

Submit data to NCIR

Page 18: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

NEW MEASURES TO STAGE 2 CORE OBJECTIVES

SECURE ELECTRONIC MESSAGING

Ability to view online,

download and transmit health

information

PATIENT ENGAGEMENT *5% of patients must

message provider

*5% of patients must access their health information online

Page 19: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

A Comparative Analysis of

Stages 1 and 2

Page 20: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

Stage 1 Objective Stage 1 Measure Stage 2 Objective Stage 2 Measure Summary of Changes

Use CPOE for medication orders directly entered by any licensed healthcare professional who can enter orders into the medical record per state, local and professional guidelines

More than 30% of unique patients with at least one medication in their medication list seen by the EP have at least one medication order entered using CPOE

Use computerized provider order entry (CPOE) for medication, laboratory and radiology orders directly entered by any licensed healthcare professional who can enter orders into the medical record per state, local and professional guidelines

More than 60% of medication, 30% of laboratory, and 30% of radiology orders created by the EP during the EHR reporting period are recorded using CPOE

*Increased

thresholds/percentages

*Additional order types

*FINAL RULE PRESENTS

ADDITIONAL CHANGES-

see additional slides for

details

Implement drug-drug and drug-allergy interaction checks

The EP has enabled this functionality for the entire EHR reporting period

No longer a separate objective for Stage 2

This measure is incorporated into the Stage 2 Clinical Decision Support measure

*Removed

Generate and transmit permissible prescriptions electronically (eRx)

More than 40% of all permissible prescriptions written by the EP are transmitted electronically using certified EHR technology

Generate and transmit permissible prescriptions electronically (eRx)

More than 50% of all permissible prescriptions written by the EP are compared to at least one drug formulary and transmitted electronically using Certified EHR Technology

*Increased from 40% to

50%

*Stage 1 Menu item

incorporated into the

Stage 2 Core Item

*FINAL RULE PRESENTS

ADDITIONAL CHANGES-

see additional slides for

details

Page 21: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

Stage 1 Objective Stage 1 Measure Stage 2 Objective Stage 2 Measure Summary of Changes

Record demographics Preferred language Gender Race Ethnicity Date of birth

More than 50% of all unique patients seen by the EP have demographics recorded as structured data

Record the following demographics Preferred language Gender Race Ethnicity Date of birth

More than 80% of all unique patients seen by the EP have demographics recorded as structured data

*Increased threshold

from 50% to 80%

Maintain an up-to-date problem list of current and active diagnoses

More than 80% of all unique patients seen by the EP have at least one entry or an indication that no problems are known for the patient recorded as structured data

No longer a separate objective for Stage 2

This measure is incorporated into the Stage 2 measure of Summary of Care Document at Transitions of Care and Referrals

*Removed

Maintain active medication list

More than 80% of all unique patients seen by the EP have at least one entry (or an indication that the patient is not currently prescribed any medication) recorded as structured data

No longer a separate objective for Stage 2

This measure is incorporated into the Stage 2 measure of Summary of Care Document at Transitions of Care and Referrals

*Removed

Page 22: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

Stage 1 Objective Stage 1 Measure Stage 2 Objective Stage 2 Measure Summary of Changes

Maintain active medication allergy list

More than 80% of all unique patients seen by the EP have at least one entry (or an indication that the patient has no known medication allergies) recorded as structured data

No longer a separate objective for Stage 2

This measure is incorporated into the Stage 2 measure of Summary of Care Document at Transitions of Care and Referrals

*Removed

Record and chart changes in vital signs: Height Weight Blood pressure Calculate and display BMI Plot and display growth charts for children 2-20 years, including BMI

For more than 50% of all unique patients age 2 and over seen by the EP, blood pressure, height and weight are recorded as structured data

Record and chart changes in vital signs: Height Weight Blood pressure (age 3 and over) Calculate and display BMI Plot and display growth charts for patients 0-20 years, including BMI

More than 80% of all unique patients seen by the EP have blood pressure (for patients age 3 and over only) and height and weight (for all ages) recorded as structured data

*Measure changes

**FINAL RULE PRESENTS

ADDITIONAL CHANGES-

see additional slides for

details

Record smoking status for patients 13 years old or older

More than 50% of all unique patients 13 years old or older seen by the EP have smoking status recorded as structured data

Record smoking status for patients 13 years old or older

More than 80% of all unique patients 13 years old or older seen by the EP have smoking status recorded as structured data

*Increased threshold

from 50% to 80%

Page 23: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

Stage 1 Objective Stage 1 Measure Stage 2 Objective Stage 2 Measure Summary of Changes

Implement one clinical decision support rule relevant to specialty or high clinical priority along with the ability to track compliance that rule

Implement one clinical decision support rule

Use clinical decision support to improve performance on high-priority health conditions

1. Implement 5 clinical decision support interventions related to 4 or more clinical quality measures, if applicable, at a relevant point in patient care for the entire EHR reporting period. 2. The EP has enabled the functionality for drug-drug and drug-allergy interaction checks for the entire EHR reporting period

*Increased number of

CDSRs must be

enabled

*Previous stage 1 core

item (drug interaction

checks) incorporated

into this stage 2

measure

Report clinical quality measures (CQMs) to CMS or the States

Provide aggregate numerator, denominator, and exclusions through attestation or through the PQRS Electronic Reporting Pilot

No longer a separate objective for Stage 2, but providers must still submit CQMs to CMS or the States in order to achieve meaningful use

Starting in 2014, all CQMs will be submitted electronically to CMS

*Removed

*Deemed as a part of

the definition of

meaningful use

*FINAL RULE PRESENTS

ADDITIONAL CHANGES-see

additional slides for details

Page 24: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

Stage 1 Objective Stage 1 Measure Stage 2 Objective Stage 2 Measure Summary of Changes

Provide patients with an electronic copy of their health information (including diagnostic test results, problem list, medication lists, medication allergies), upon request

More than 50% of all patients of the EP who request an electronic copy of their health information are provided it within 3 business days

Provide patients the ability to view online, download and transmit their health information within four business days of the information being available to the EP

i. More than 50% of all unique patients seen by the EP during the EHR reporting period are provided timely (available to the patient within 4 business days after the information is available to the EP) online access to their health information ii. More than 5% of all unique patients seen by the EP during the EHR reporting period (or their authorized representatives) view, download, or transmit to a third party their health information

*New

*Changed from “upon

request” to a

requirement

*Additional

requirement that

patient must access

their health

information

*PATIENT

ENGAGEMENT

*FINAL RULE

PRESENTS

ADDITIONAL

CHANGES-see

additional slides for

details

Page 25: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

Stage 1 Objective Stage 1 Measure Stage 2 Objective Stage 2 Measure Summary of Changes

Provide clinical summaries for patients for each office visit

Clinical summaries provided to patients for more than 50% of all office visits within 3 business days

Provide clinical summaries for patients for each office visit

Clinical summaries provided to patients within one business day for more than 50% of office visits

*Decreased time to

provide clinical

summaries

Capability to exchange key clinical information (for example, problem list, medication list, medication allergies, diagnostic test results), among providers of care and patient authorized entities electronically

Performed at least one test of certified EHR technology's capacity to electronically exchange key clinical information

This objective is eliminated from Stage 1 in 2013 and is no longer an objective for Stage 2

This measure is eliminated from Stage 1 in 2013 and is no longer a measure for Stage 2

*Removed

*FINAL RULE PRESENTS

ADDITIONAL CHANGES-

see additional slides for

details

Protect electronic health information created or maintained by the certified EHR technology through the implementation of appropriate technical capabilities

Conduct or review a security risk analysis per 45 CFR 164.308 (a)(1) and implement security updates as necessary and correct identified security deficiencies as part of its risk management process

Protect electronic health information created or maintained by the Certified EHR Technology through the implementation of appropriate technical capabilities.

Conduct or review a security risk analysis in accordance with the requirements under 45 CFR 164.308 (a)(1), including addressing the encryption/security of data at rest and implement security updates as necessary and correct identified security deficiencies as part of its risk management process

*None

*Please review new

HIPAA Omnibus Final

Rule

Page 26: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

Stage 1 Objective Stage 1 Measure Stage 2 Objective Stage 2 Measure Summary of Changes

Implement drug-formulary checks (MENU)

The EP has enabled this functionality and has access to at least one internal or external drug formulary for the entire EHR reporting period

No longer a separate objective for Stage 2

This measure is incorporated into the e-Prescribing measure for Stage 2

*Removed

Incorporate clinical lab-test results into certified EHR technology as structured data (MENU)

More than 40% of all clinical lab tests results ordered by the EP during the EHR reporting period whose results are either in a positive/negative or numerical format are incorporated in certified EHR technology as structured data

Incorporate clinical lab-test results into Certified EHR Technology as structured data (CORE)

More than 55% of all clinical lab tests results ordered by the EP during the EHR reporting period whose results are either in a positive/negative or numerical format are incorporated in Certified EHR Technology as structured data

*Moved from menu to

core

*Increased threshold

from 40% to 55%

Generate lists of patients by specific conditions to use for quality improvement, reduction of disparities, research or outreach (MENU)

Generate at least one report listing patients of the EP with a specific condition

Generate lists of patients by specific conditions to use for quality improvement, reduction of disparities, research, or outreach (CORE)

Generate at least one report listing patients of the EP with a specific condition

*Moved from menu to

core

Page 27: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

Stage 1 Objective Stage 1 Measure Stage 2 Objective Stage 2 Measure Summary of changes

Send reminders to patients per patient preference for preventive/ follow up care (MENU)

More than 20% of all unique patients 65 years or older or 5 years old or younger were sent an appropriate reminder during the EHR reporting period

Use clinically relevant information to identify patients who should receive reminders for preventive/follow-up care (CORE)

Use EHR to identify and provide reminders for preventive/follow-up care for more than 10% of patients with two or more office visits in the last 2 years

*Measure change

Provide patients with timely electronic access to their health information (including lab results, problem list, medication lists, medication allergies) within four business days of the information being available to the EP (MENU)

More than 10% of all unique patients seen by the EP are provided timely (available to the patient within four business days of being updated in the certified EHR technology) electronic access to their health information subject to the EP’s discretion to withhold certain information

This objective is eliminated from Stage 1 in 2014 and is no longer an objective for Stage 2

This measure is eliminated from Stage 1 in 2014 and is no longer a measure for Stage 2

*Removed

*FINAL RULE PRESENTS

ADDITIONAL CHANGES-

see additional slides for

details

Page 28: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

Stage 1 Objective Stage 1 Measure Stage 2 Objective Stage 2 Measure Summary of Changes

Use certified EHR technology to identify patient-specific education resources and provide those resources to the patient if appropriate (MENU)

More than 10% of all unique patients seen by the EP are provided patient-specific education resources

Use certified EHR technology to identify patient-specific education resources and provide those resources to the patient if appropriate (CORE)

Patient-specific education resources identified by CEHRT are provided to patients for more than 10% of all unique patients with office visits seen by the EP during the EHR reporting period

*Moved from menu to

core

The EP who receives a patient from another setting of care or provider of care or believes an encounter is relevant should perform medication reconciliation (MENU)

The EP performs medication reconciliation for more than 50% of transitions of care in which the patient is transitioned into the care of the EP

The EP who receives a patient from another setting of care or provider of care or believes an encounter is relevant should perform medication reconciliation (CORE)

The EP performs medication reconciliation for more than 50% of transitions of care in which the patient is transitioned into the care of the EP

*Moved from menu to

core

Page 29: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

Stage 1 Objective Stage 1 Measure Stage 2 Objective Stage 2 Measure Any additional changes?

The EP who transitions their patient to another setting of care or provider of care or refers their patient to another provider of care should provide summary of care record for each transition of care or referral (MENU)

The EP who transitions or refers their patient to another setting of care or provider of care provides a summary of care record for more than 50% of transitions of care and referrals

The EP who transitions their patient to another setting of care or provider of care or refers their patient to another provider of care should provide summary of care record for each transition of care or referral (CORE)

Provide summary of care document for more than 50% of transitions of care and referrals with 10% sent electronically and at least one sent to a recipient with a different EHR vendor or a CMS test system

*Moved from menu to

core

*Health information

exchange required

Capability to submit electronic data to immunization registries or Immunization Information Systems and actual submission except where prohibited and in accordance with applicable law and practice (MENU)

Performed at least one test of certified EHR technology's capacity to submit electronic data to immunization registries and follow up submission if the test is successful (unless none of the immunization registries to which the EP submits such information have the capacity to receive the information electronically)

Capability to submit electronic data to immunization registries or Immunization Information Systems and actual submission except where prohibited and in accordance with applicable law and practice (CORE)

Successful ongoing submission of electronic immunization data from Certified EHR Technology to an immunization registry or immunization information system for the entire EHR reporting period

*Moved from menu to

core

Page 30: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

Stage 1 Objective Stage 1 Measure Stage 2 Objective Stage 2 Measure Any additional

changes?

New Stage 2 Measure (Not a Stage 1 Measure)

New Stage 2 Measure (Not a Stage 1 Measure)

Use secure electronic messaging to communicate with patients on relevant health information

A secure message was sent using the electronic messaging function of Certified EHR Technology by more than 5% of unique patients seen during the EHR reporting period

NO

Page 31: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

Stage 2 MENU Objective Stage 2 MENU Measure

Imaging Results More than 10% of imaging results are accessible

through Certified EHR Technology

Family History Record family health history for more than 20%

Syndromic Surveillance Successful ongoing transmission of syndromic surveillance data

Cancer Successful ongoing transmission of cancer case information

Specialized Registry Successful ongoing transmission of data to a specialized registry

Progress Notes Enter an electronic progress note for more than 30% of unique patients

Page 32: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

CMS Stage 2 Final Rule:

Stage 1 Changes

Page 33: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

• Exchange of key clinical information—no longer required in 2013

• Clinical Quality Measures—no longer separate core objective in 2013, but still required to report CQMs

2013 STAGE 1 CHANGES

Page 34: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

2013 STAGE 1 CHANGES

• CPOE—optional alternate measure in 2013 that becomes required in 2014 for stage 2 attesters

• You will always have 2 options for stage 1

• e-Prescribing—new exclusion added effective 2013

• Providers not within a 10 mile radius of a pharmacy that accepts electronic prescriptions

• Vital Signs—optional new measure and exclusions in 2013 that becomes required in 2014

Page 35: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

• Electronic Copy of and Electronic Access to Health Information (core and menu)—Replaced with the requirement that you must provide patients ability to view online, download, and transmit their health information within 4 days (to more than 50% of unique patients seen by EP)

• Menu Exclusions—can’t claim exclusion if there are other objectives you can meet

• *Vital Signs—optional new stage 1 measure in 2013 becomes required stage 1 measure

• This impacts both stages in 2014

2014 STAGE 1 CHANGES

Page 36: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

• In 2014, providers will have to upgrade to or adopt certified systems that meet the 2014 certification criteria

• 2014 3 month reporting period NO MATTER THE STAGE YOU ARE REPORTING

• 2014 Batch Reporting for Core and Menu Items

CMS STAGE 2 FINAL RULE: ADDITIONAL CHANGES

Page 37: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

PAYMENT ADJUSTMENTS & HARDSHIP EXEMPTIONS

Page 38: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

• Infrastructure (in an area without internet access)

• Unforeseen circumstances (example: natural disaster)

• New EP’s (newly practicing providers who haven’t had time to meet MU can apply for 2 year extension)

• By specialist/provider type (certain provider types may meet 3 required areas to be exempt)

Follow link for more information

http://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/Downloads/PaymentAdj_HardshipExcepTipSheetforEP.pdf

PAYMENT ADJUSTMENTS & HARDSHIP EXEMPTIONS

Page 39: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

• Now includes zero pay claims

• Under Stage 2 rule (applicable to all stages), States also have option to allow providers to calculate Medicaid patient volume across 90-day period in last 12 months preceding provider’s attestation

MEDICAID VOLUME CALCULATION CHANGES

Page 40: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

Stage 1: Meaningful use criteria focus on:

Stage 2: Meaningful use criteria focus on:

Stage 3: Meaningful use criteria focus on:

Electronically capturing health information in a standardized format

More rigorous health information exchange (HIE)

Improving quality, safety, and efficiency, leading to improved health outcomes

Using that information to track key clinical conditions

Increased requirements for e-prescribing and incorporating lab results

Decision support for national high-priority conditions

Communicating that information for care coordination processes

Electronic transmission of patient care summaries across multiple settings

Patient access to self-management tools

Initiating the reporting of clinical quality measures and public health information

More patient-controlled data Access to comprehensive patient data through patient-centered HIE

Using information to engage patients and their families in their care

Improving population health

THE MEANING BEHIND IT ALL…

Page 42: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

FOR COMPLETE STAGE 2 INFORMATION…

Stage 1 Changes Tip Sheet http://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/Downloads/Stage1ChangesTipsheet.pdf CMS Webpage with several stage 2 links http://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/Stage_2.html MU Stage 2 Final Rule http://www.ofr.gov/(X(1)S(uzclbwrx5fwqm2w2mipkysrh))/OFRUpload/OFRData/2012-21050_PI.pdf

42

Page 43: THE MEANING OF MEANINGFUL USE - Appeal Academyappealacademy.com/wp-content/uploads/2013/02/... · Implement one clinical decision support rule relevant to specialty or high clinical

RESOURCES/REFERENCES

• Healthit.gov

• US Department of Health and Human Services

• ONC Website

• CMS Stage 2 MU Final Rule

• CCME (ccmeconsulting.org)

• CMS Website

• Stage 1 Changes Tipsheet

• Stage 1 vs. Stage 2 Comparison